Top Pharmaceutical Stocks To Watch Now – November 17th

SELLAS Life Sciences Group, Eli Lilly and Company, and Johnson & Johnson are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of companies that research, develop, manufacture, or sell medicines and related treatments. For investors, their value can be influenced by factors such as clinical-trial results, regulatory approvals, patent protection, drug demand, and competition. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company’s lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.

Shares of NASDAQ:SLS traded up $12.20 during midday trading on Tuesday, hitting $19.67. 89,964,876 shares of the company’s stock were exchanged, compared to its average volume of 8,232,931. The company has a market cap of $3.97 billion, a PE ratio of -98.36 and a beta of 2.73. The stock has a 50 day moving average price of $10.90 and a 200-day moving average price of $8.79. SELLAS Life Sciences Group has a 12 month low of $1.39 and a 12 month high of $24.89.

Read Our Latest Research Report on SLS

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY stock traded down $16.65 during trading on Tuesday, hitting $1,415.02. The company’s stock had a trading volume of 1,126,930 shares, compared to its average volume of 2,950,144. Eli Lilly and Company has a 52 week low of $850.51 and a 52 week high of $1,475.25. The business has a fifty day moving average of $1,247.93 and a 200-day moving average of $1,112.33. The company has a current ratio of 1.39, a quick ratio of 1.00 and a debt-to-equity ratio of 1.17. The company has a market cap of $1.33 trillion, a PE ratio of 45.91, a P/E/G ratio of 1.71 and a beta of 0.40.

Read Our Latest Research Report on LLY

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

NYSE JNJ traded down $2.71 on Tuesday, hitting $279.84. 2,204,532 shares of the stock traded hands, compared to its average volume of 7,926,807. The business’s fifty day moving average is $267.12 and its two-hundred day moving average is $250.12. Johnson & Johnson has a 12 month low of $198.53 and a 12 month high of $290.25. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.02. The firm has a market capitalization of $673.66 billion, a price-to-earnings ratio of 42.40, a PEG ratio of 2.80 and a beta of 0.22.

Read Our Latest Research Report on JNJ

Further Reading